First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa School of Medicine, 6 viale Benedetto XV, 13132, Genoa, Italy.
Struttura Organizzativa Dipartimentale di Radiodiagnostica 2, Dipartimento di Scienze Biomediche, Sperimentali e Cliniche, Università degli Studi di Firenze, Azienda Ospedaliero-Universitaria Careggi, 3 Largo Brambilla, 50134, Florence, Italy.
Transl Stroke Res. 2019 Apr;10(2):178-188. doi: 10.1007/s12975-018-0637-8. Epub 2018 Jun 14.
Cerebral reperfusion and arterial recanalization are radiological features of the effectiveness of thrombolysis in acute ischemic stroke (AIS) patients. Here, an investigation of the prognostic role of early recanalization/reperfusion on clinical outcome was performed. In AIS patients (n = 55), baseline computerized tomography (CT) was performed ≤ 8 h from symptom onset, whereas CT determination of reperfusion/recanalization was assessed at 24 h. Multiple linear and logistic regression models were used to correlate reperfusion/recanalization with radiological (i.e., hemorrhagic transformation, ischemic core, and penumbra volumes) and clinical outcomes (assessed as National Institutes of Health Stroke Scale [NIHSS] reduction ≥ 8 points or a NIHSS ≤ 1 at 24 h and as modified Rankin Scale [mRS] < 2 at 90 days). At 24 h, patients achieving radiological reperfusion were n = 24, while the non-reperfused were n = 31. Among non-reperfused, n = 15 patients were recanalized. Radiological reperfusion vs. recanalization was also confirmed by early increased levels of circulating inflammatory biomarkers (i.e., serum osteopontin). In multivariate analysis, ischemic lesion volume reduction was associated with both recanalization (β = 0.265; p = 0.014) and reperfusion (β = 0.461; p < 0.001), but only reperfusion was independently associated with final infarct volume (β = - 0.333; p = 0.007). Only radiological reperfusion at 24 h predicted good clinical response at day 1 (adjusted OR 16.054 [1.423-181.158]; p = 0.025) and 90-day good functional outcome (adjusted OR 25.801 [1.483-448.840]; p = 0.026). At ROC curve analysis the AUC of reperfusion was 0.777 (p < 0.001) for the good clinical response at 24 h and 0.792 (p < 0.001) for 90-day clinical outcome. Twenty-four-hour radiological reperfusion assessed by CT is associated with good clinical response on day 1 and good functional outcome on day 90 in patients with ischemic stroke.
脑再灌注和动脉再通是急性缺血性脑卒中(AIS)患者溶栓治疗效果的影像学特征。在这里,我们研究了早期再通/再灌注对临床结局的预后作用。在 AIS 患者(n=55)中,基线计算机断层扫描(CT)在发病后 8 小时内进行,而 CT 确定再灌注/再通在 24 小时时进行评估。使用多元线性和逻辑回归模型将再灌注/再通与影像学(即出血性转化、缺血核心和半影体积)和临床结局(评估为 24 小时时 NIHSS 降低≥8 分或 NIHSS≤1,90 天时 mRS<2)相关联。在 24 小时时,达到影像学再灌注的患者 n=24,而未再灌注的患者 n=31。在未再灌注的患者中,n=15 名患者再通。非再灌注患者的再通也通过循环炎症生物标志物(即血清骨桥蛋白)的早期升高水平得到确认。在多变量分析中,缺血性病变体积的减少与再通(β=0.265;p=0.014)和再灌注(β=0.461;p<0.001)均相关,但只有再灌注与最终梗死体积独立相关(β=-0.333;p=0.007)。只有 24 小时的影像学再灌注可预测第 1 天的良好临床反应(调整后的 OR 16.054 [1.423-181.158];p=0.025)和 90 天的良好功能结局(调整后的 OR 25.801 [1.483-448.840];p=0.026)。在 ROC 曲线分析中,再灌注的 AUC 为 0.777(p<0.001),用于预测 24 小时时的良好临床反应,为 0.792(p<0.001),用于预测 90 天的临床结局。缺血性脑卒中患者 24 小时的 CT 评估的影像学再灌注与第 1 天的良好临床反应和第 90 天的良好功能结局相关。